The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
Modulating GPR88 activity is suggested to have therapeutic utility in the treatment of CNS disorders, such as schizophrenia. This Letter will describe the discovery and SAR development of a class of potent GPR88 agonists.